Terns Pharmaceuticals Inc. buy BiotechBee
Start price
24.06.23
/
60%
€8.87
Target price
31.12.25
€18.00
Performance (%)
-45.26%
End price
01.10.23
€4.86
Summary
This prediction ended on 01.10.23 with a price of €4.86. Massive losses of -45.26% were the result for the BUY prediction by BiotechBee. BiotechBee has 60% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Terns Pharmaceuticals Inc. | 12.844% | 12.844% |
iShares Core DAX® | -0.683% | 1.890% |
iShares Nasdaq 100 | 0.335% | 4.631% |
iShares Nikkei 225® | -1.486% | -2.361% |
iShares S&P 500 | -0.523% | 2.324% |
According to BiotechBee what are the pros and cons of Terns Pharmaceuticals Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Terns Pharmaceuticals Inc. diskutieren
Buy mit Kursziel 18,0
In the thread Trading Terns Pharmaceuticals Inc.
Buy beendet